Global Nonalcoholic Steatohepatitis Treatment (Phase III Drugs) Market USD 19.8 Billion by 2025
Summary
NAFLD spans a spectrum of clinicopathologic entities from simple hepatic steatosis to nonalcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma.iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.Contact Us iHealthcareAnalyst, Inc. 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043 United States Email: sales@ihealthcareanalyst.com Website: https://www.ihealthcareanalyst.com Maryland Heights, MO, December 01, 2016 --( PR.com )-- The global nonalcoholic steatohepatitis treatment (Phase III Drugs) market is estimated to reach USD 19.5 Billion in 2025, expanding at a CAGR of 10.0% from 2016 to 2025, published by iHealthcareAnalyst, Inc.Visit the Nonalcoholic Steatohepatitis Treatment Market – Phase III Drugs In Pipeline (Obeticholic Acid, Aramchol, Saroglitazar, and Elafibranor) 2016-2025 report at https://www.ihealthcareanalyst.com/report/nonalcoholic-steatohepatitis-treatment-market/Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver.NAFLD spans a spectrum of clinicopathologic entities from simple hepatic steatosis to nonalcoholic steatohepatitis, cirrhosis, and hepatocellular carcinoma.The global nonalcoholic steatohepatitis treatment market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.Major players operating in the global nonalcoholic steatohepatitis treatment market and included in this report are Pharmaceuticals Inc., Galmed Pharmaceuticals Ltd., GENFIT SA, and Zydus Cadila.To request Table of Contents and Sample Pages of this report visit:https://www.ihealthcareanalyst.com/report/nonalcoholic-steatohepatitis-treatment-market/About UsiHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients.